Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
USWM CT, LLC
Study ID
NCT03391778
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Neoplasms

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • ADP adoptive cell therapy — BIOLOGICAL
    No study drug is administered in this study. Participants who received ADP adoptive cell therapy in a previous trial will be evaluated in this trial for long-term safety and efficacy.

Study Details

This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.

Key Dates

Start date
Apr 9, 2018
Status verified
Feb 2026
Primary completion
Apr 1, 2032
Completion
Apr 1, 2032

Study Design

Enrollment
250 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Participants receiving ADP adoptive cell therapy

Primary Outcome Measure

Number of participants with delayed adverse events (AEs) and serious adverse events (SAEs) [ Time Frame: 15 years post last treatment ]

Central Contacts

Locations (13)

FacilityCityStateZIPSite coordinators
Emory University School of MedicineAtlantaGeorgia30322
Clinical Trials Call Center
Melinda Yushak (PRINCIPAL_INVESTIGATOR)
ADP Investigational SiteBaltimoreMaryland21201
Clinical Trial Inquiries
Aaron Rapoport (PRINCIPAL_INVESTIGATOR)
National Cancer Institute - Center for Cancer ResearchBethesdaMaryland20892-
University of MichiganAnn ArborMichigan48109
Clinical Trial Inquiries
Rashmi Chugh (PRINCIPAL_INVESTIGATOR)
Washington University School of Medicine in St. LouisSt LouisMissouri63110
Clinical Trial Inquiries
Brian Van Tine (PRINCIPAL_INVESTIGATOR)
Memorial Sloan Kettering Cancer Center - New YorkNew YorkNew York10065
MSKCC Clinical Trials Office
Sandra P D'Angelo (PRINCIPAL_INVESTIGATOR)
Duke University Medical CenterDurhamNorth Carolina27710
Clinical Trial Inquiries
Richard Riedel (PRINCIPAL_INVESTIGATOR)
Oregon Health and Science UniversityPortlandOregon97239
Clinical Trial Inquiries
Lara Davis (PRINCIPAL_INVESTIGATOR)
University of PennsylvaniaPhiladelphiaPennsylvania19104
Clinical Trial Inquiries
Edward A Stadtmauer (PRINCIPAL_INVESTIGATOR)
University of Pittsburgh Medical Center (UPMC) Hillman Cancer CenterPittsburghPennsylvania15232
Clinical Trial Inquiries
Melissa Burgess (PRINCIPAL_INVESTIGATOR)
University of Texas Southwestern Medical CenterDallasTexas75390
Clinical Trial Inquiries
John Samuel (PRINCIPAL_INVESTIGATOR)
University of Texas MD Anderson Cancer CenterHoustonTexas77030
Clinical Trial Inquiries
Dejka Araujo (PRINCIPAL_INVESTIGATOR)
Froedtert HospitalMilwaukeeWisconsin53226
Clinical Trial Inquiries
John A Charlson (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

By research site
Emory University School of Medicine· Atlanta, GAADP Investigational Site· Baltimore, MDNational Cancer Institute - Center for Cancer Research· Bethesda, MDUniversity of Michigan· Ann Arbor, MIWashington University School of Medicine in St. Louis· St Louis, MOMemorial Sloan Kettering Cancer Center - New York· New York, NY

Related Studies